Early research suggests that dupilumab, a monoclonal antibody used to treat asthma and eczema, may benefit patients hospitalized with moderate-to-severe COVID-19.
In a recent study published in Open Forum Infectious Diseases, a clinical study led by the University of Virginia (UVA) Health System found that the drug, | Drug Discovery And Development
A clinical trial conducted by UVA Health suggests that a monoclonal antibody used to treat asthma and eczema may reduce the risk of death for patients with moderate to severe cases of COVID-19.
Researchers Find Medicine for Asthma and Eczema Helps COVID Patients miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.